Skip to content

A Clinical Trial (Preliminary Studies) to Evaluate the Safety and Effectiveness of the Implantable prostate suspension system for the Treatment of Benign Prostatic Hyperplasia

A Clinical Trial (Preliminary Studies) to Evaluate the Safety and Effectiveness of the Implantable prostate suspension system for the Treatment of Benign Prostatic Hyperplasia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057309
Enrollment
Unknown
Registered
2022-03-07
Start date
2021-06-17
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostate Hyperplasia

Interventions

Urowell group:Prostatic Urethral Lift

Sponsors

Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
53 Years to 71 Years

Inclusion criteria

Inclusion criteria: 1. Age>=50 years old, male; 2. IPSS>12; 3. Qmax<=15ml/s(125 ml urine); 4. Voluntarily sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Acute urinary tract infection; 2. Gross hematuria; 3. Prostate volume>80 mL; 4. Difficulty in inserting instruments; 5. Developed bacterial prostatitis within 3 months; 6. Serum Prostate Specific Antigen (PSA)>10ug/L; 7. Bladder dysfunction caused by neurogenic bladder or other factors; 8. Operation History of Transurethral resection of the prostate (TURP) or laser surgery; 9. Complicated with serious cardiovascular disease; 10. Use of anticoagulants within 3 days (excluding aspirin less than 100 mg); 11. Patients allergic to nickel titanium or stainless steel; 12. The patient has participated in clinical trials other than registration studies within 3 months; 13. Other circumstances that the investigator considers inappropriate for participation in the study.

Design outcomes

Primary

MeasureTime frame
International Prostate Symptom Score, IPSS;

Secondary

MeasureTime frame
Qmax;Post-void residual volume, PVR;Quality of Life, QOL;Sexual Health Inventory for Men, SHIM;Male Sexual Health Questionnaire for Ejaculatory Dysfunction, MSHQ-EjD;MSHQ-Bother;Immediate postoperative success rate;Device performance evaluation;

Countries

China

Contacts

Public ContactCheng Fan

Renmin Hospital of Wuhan University

urology1969@aliyun.com+86 13307105017

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026